Drug Shortage Report for BOOSTRIX-POLIO

Last updated on 2017-12-07 History
Report ID 19888
Drug Identification Number 02312557
Brand name BOOSTRIX-POLIO
Common or Proper name Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) INACTIVATED POLIOVIRUS TYPE I INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE III TETANUS TOXOID ADSORBED DIPHTHERIA TOXOID ADSORBED PERTUSSIS TOXOID ADSORBED FILAMENTOUS HAEMAGGLUTININ ADSORBED PERTACTIN ADSORBED
Strength(s) 40D 8D 32D 5.0LF 2.5LF 8MCG 8MCG 2.5MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 10's
ATC code J07CA
ATC description BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-11-08
Estimated end date 2017-12-07
Actual end date 2017-12-06
Shortage status Resolved
Updated date 2017-12-07
Company comments Supply released November 10, 2017 with limited quantity.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2017-12-07 French Compare
v25 2017-12-07 English Compare
v24 2017-11-14 French Compare
v23 2017-11-14 English Compare
v22 2017-11-09 English Compare
v21 2017-11-08 French Compare
v20 2017-11-08 French Compare
v19 2017-11-08 English Compare
v18 2017-11-01 French Compare
v17 2017-11-01 English Compare
v16 2017-10-25 French Compare
v15 2017-10-25 English Compare
v14 2017-10-18 French Compare
v13 2017-10-18 English Compare
v12 2017-10-11 French Compare
v11 2017-10-11 English Compare
v10 2017-10-04 French Compare
v9 2017-10-04 English Compare
v8 2017-09-27 French Compare
v7 2017-09-27 English Compare

Showing 1 to 20 of 26